Can Rare Cancer Drugs Expect Sales in Japan?: A Prescription Pattern Analysis of Drugs for Chronic Myelogenous Leukemia and Neuroendocrine Tumor. regsci. 2019;7:1-9. doi:10.21423/JRS-V07SHIBATA